Abstract
Objective
The purpose of this paper was to evaluate the efficacy of intra-articular (AI) injections of Hyaluronic Acid (HA) versus Oxygen-Ozone (O2O3) in relieving pain and reducing disability in patients affected by knee osteoarthritis (KOA).
Methods
People with painful KOA for at least three months were randomly allocated to receive three IA injections, once a week, of HA (Group A) vs O2O3 (Group B). They were evaluated at baseline (T0), at 1 (T1), 3 (T2), 6 (T3), and 12 months (T4) after the treatment, using as outcomes: WOMAC pain score, WOMAC LK 3.1, Numeric Rating Scale (NRS), and KOOS.
Results
Of the 122 patients assessed for eligibility, 112 participants were enrolled. Both groups A and B showed significant improvements in all outcomes measures from 1 month after the treatment (HA Group: 6.77 ± 2.53 vs 3.66 ± 2.57; O2O3 Group: 6.50 ± 2.24 vs 3.45 ± 2.30). In contrast, at T2 and T3, the HA-treated group showed significant pain and functional improvement compared to O2O3 group.
Conclusion
Both HA and O2O3 might be considered safe and potential effective treatments for KOA, due to their anti-inflammatory effects. O2O3 seems to have a faster effect; rather, HA showed superior efficacy at 3 months onwards from the end of the treatment.
Get full access to this article
View all access options for this article.
